Celularity Inc 8-K

What Happened

• Celularity Inc. (CELU) filed an 8-K reporting that on June 9, 2026 it received a written notice from the Nasdaq Listing Qualifications Staff saying the company’s Market Value of Listed Securities (MVLS) was below the $35.0 million minimum required for continued listing on the Nasdaq Capital Market. The shortfall was based on the 30 consecutive business days prior to the notice.
• Nasdaq has given Celularity 180 calendar days — until December 7, 2026 — to regain compliance. The company’s shares are not immediately delisted.

Key Details

• Nasdaq rule cited: Listing Rule 5550(b)(2) (MVLS Requirement); notice dated June 9, 2026.
• Compliance deadline: 180 days, through December 7, 2026; to regain compliance the MVLS must be ≥ $35.0 million for at least 10 consecutive business days (unless Nasdaq exercises discretion to extend).
• Alternatives noted by the company: actively monitor market value and consider actions to regain compliance, including potentially increasing stockholders’ equity to at least $2.5 million.
• If Celularity does not regain compliance by the deadline, Nasdaq will notify the company that its securities are subject to delisting; Celularity can appeal that determination.

Why It Matters

• For investors, this filing signals that Celularity’s market capitalization has fallen below Nasdaq’s minimum for continued listing, creating a 180-day window to remedy the situation. If unresolved, the company could face delisting proceedings, which can reduce liquidity and investor access to the stock. The filing is procedural and does not predict the outcome; it simply sets the timeline and criteria for regaining compliance.